histor perform last quarter ep quarter averag
day earn move averag
yet continu impress us anoth ep beat came st estim buysid
probabl get use ep surpris vs st estim think magnitud ep beat perceiv
posit driven lower tax rate vs model still think headlin impress
straight big ep beat organ revenu came bp model possibl
bp better st beat driven renal bode well light recent settlement pharmaceut
would interest hear time impact partli off-set slightli lower medic deliveri
nutrit within gross margin came topic debat off-set lower expens
higher incom contribut lower tax rate contribut revenu guidanc rais bp organ
ep rais new rang seem littl conserv given magnitud beat
need detail assumpt overal thought solid print back detail post call
posit us actual sale ou sale vs consensu respect
posit ep guidanc rais strong print
neutral neg oper margin in-lin y/i lower gross margin off-set better sg manag
neutral ep guidanc in-lin st like conserv optic seem low given huge
result tabl next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
increas competit price pressur fluid system fda qualiti issu tax reform uncertainti inabl
articl articl
time dissemin april et
analyst vijay kumar primarili respons prepar research report attest follow view opinion
render research report reflect person view subject compani issuer part research
analyst compens directli relat specif recommend view research report
